Keywords: eli, lilly, eps, forecast, beats, expectations, firm
Eli Lilly's 2008 EPS forecast beats expectations as firm prepares for patent loses
Article | 17 December 2007
At its annual investors meeting, US drug major Eli Lilly reconfirmed its 2007 financial guidance and predicted 2008 earnings above Wall Street ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
